Your Partners in Proactive Viral Defense
Your Partners in Proactive Viral Defense
our mission
Translate the novel pharmacology of lambda carrageenan into virus-agnostic, preventative antiviral treatments supported by the qualified, science-based claims.
Translate the novel pharmacology of lambda carrageenan into virus-agnostic, preventative antiviral treatments supported by the qualified, science-based claims.
Derisking the Future of Preventative Antivirals
Derisking the Future of Preventative Antivirals
Consumer trust in preventative treatments has eroded because of past unsubstantiated claims. We are addressing this by committing to science-based claims for our pre-exposure prophylaxis treatments, thus establishing a clear competitive advantage.
Consumer trust in preventative treatments has eroded because of past unsubstantiated claims. We are addressing this by committing to science-based claims for our pre-exposure prophylaxis treatments, thus establishing a clear competitive advantage.
Secure Global IP
Develop and maintain a strong global IP portfolio for antiviral formulations based on lambda carrageenans.
Develop and maintain a strong global IP portfolio for antiviral formulations based on lambda carrageenans.
Conduct Clinical Studies
Conduct the entire series of human preclinical and clinical studies to support commercial claims.
Conduct the entire series of human preclinical and clinical studies to support commercial claims.
Manufacture
Develop a best-in-class product supply network to ensure the highest quality and safety standards for our products.
Develop a best-in-class product supply network to ensure the highest quality and safety standards for our products.
Commercialize
Develop and market our own products or secure commercial partnerships with category leaders.
Develop and market our own products or secure commercial partnerships with category leaders.
Our Team
Our Team
We bring together world-class experts from pharmaceutical and consumer products categories.
We bring together world-class experts from pharmaceutical and consumer products categories.
Toby Cosgrove, MD
Toby Cosgrove, MD
Toby Cosgrove, MD
Chairman
Chairman
Chairman
Debra Bass
Debra Bass
Debra Bass
Chief Executive Officer
Chief Executive Officer
Chief Executive Officer
Brad Barron
Brad Barron
Brad Barron
Chief Innovation Officer
Chief Innovation Officer
Chief Innovation Officer
Susan Nicholson, MD, FIDSA
Susan Nicholson, MD, FIDSA
Susan Nicholson, MD, FIDSA
Chief Medical Officer
Chief Medical Officer
Chief Medical Officer
Dennis Ossipov-Grodsky
Dennis Ossipov-Grodsky
Dennis Ossipov-Grodsky
Chief Commercial Officer
Chief Commercial Officer
Chief Commercial Officer
Mary Guilfoyle, MS, Biostatistics
Mary Guilfoyle, MS, Biostatistics
Mary Guilfoyle, MS, Biostatistics
SVP, Clinical Affairs
SVP, Clinical Affairs
SVP, Clinical Affairs
James W. Arbogast, PhD, Organic Chemistry
James W. Arbogast, PhD, Organic Chemistry
James W. Arbogast, PhD, Organic Chemistry
SVP, R&D
SVP, R&D
SVP, R&D
Abel Saud, MS, Chemical Engineering
Abel Saud, MS, Chemical Engineering
Abel Saud, MS, Chemical Engineering
SVP, Innovation
SVP, Innovation
SVP, Innovation
James Kaleta
James Kaleta
James Kaleta
SVP, Procurement
SVP, Procurement
SVP, Procurement
Mario Tremblay, PhD, Chemistry
Mario Tremblay, PhD, Chemistry
Mario Tremblay, PhD, Chemistry
Chemistry and R&D Advisor
Chemistry and R&D Advisor
Chemistry and R&D Advisor
© 2025 Lanvira™. All rights reserved.
© 2025 Lanvira™. All rights reserved.
© 2025 Lanvira™. All rights reserved.